Gujarat FDCA Forms Special Flying Squads To Combat Sale Of Adulterated, Counterfeit & Spurious Medicines

Mumbai: In a groundbreaking initiative to tackle the sale of adulterated, counterfeit, and spurious medicines, the Gujarat Food and Drug Control Administration (FDCA) has formed special flying squads for the first time in the state’s history. These squads, comprising two enforcement teams each, are led by an assistant commissioner and include senior drug inspectors and drug inspectors. This strategic move has been approved by the state government to enhance surveillance and monitoring across the pharmaceutical supply chain.

Dr HG Koshia, the FDCA Commissioner, hailed the formation of these squads as a “landmark move” in ensuring the safety and efficacy of medicines available in the market. “In order to curb the clandestine activity involving the sale of adulterated, counterfeit, and spurious medicines, Gujarat FDCA has set up a special flying squad of two enforcement teams each headed by an assistant commissioner and comprising senior drug inspectors and drug inspectors for the first time in Gujarat for effective surveillance and monitoring,” stated Dr. Koshia.

The enforcement teams have been meticulously selected from a pool of 175 officers within the Gujarat FDCA’s enforcement department, based on their competence and track record. These squads are tasked with monitoring the entire supply chain, which includes over 6,000 manufacturers and around 55,000 wholesalers and retailers across Gujarat.

The primary objective of these squads is to conduct regular and surprise inspections, ensure compliance with drug safety regulations, and take stringent actions against violators. By doing so, the FDCA aims to safeguard public health and maintain the integrity of the pharmaceutical market.

Dr. Koshia emphasized the importance of this initiative, stating, “The formation of these squads marks a significant step towards ensuring that only safe and genuine medicines reach the consumers. We are committed to maintaining the highest standards of drug safety and will take all necessary measures to eliminate any threats posed by adulterated and counterfeit drugs.”

Related Posts

  • Pharma
  • April 30, 2025
  • 92 views
Centre notifies rules for compounding of offences under Drugs & Cosmetics Act

New Delhi:   The union health ministry has notified the Drugs & Cosmetics (Compounding of Offences) Rules 2025 to allow minor offences to be settled by fine or penalties. His is…

  • Pharma
  • April 30, 2025
  • 91 views
US FDA approves first cell-based gene therapy for rare genetic skin disorder

The U.S. Food and Drug Administration approved Abeona Therapeutics’ (ABEO.O), opens new tab gene therapy for a rare skin disorder on Tuesday. The gene therapy, called Zevaskyn, is approved to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Centre notifies rules for compounding of offences under Drugs & Cosmetics Act

Centre notifies rules for compounding of offences under Drugs & Cosmetics Act

US FDA approves first cell-based gene therapy for rare genetic skin disorder

US FDA approves first cell-based gene therapy for rare genetic skin disorder

Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

Cargologic receives CEIV Pharma re-certification

Cargologic receives CEIV Pharma re-certification